IL1B and Miyoshi myopathy: It was found out that miR-22 could cause adverse effect on activating NLRP3 inflammasome by targeting to reduce the cell apoptosis in subcutaneous tissues of cutaneous MM mouse models and regulate IL-18 and IL-1β.